NeuBase Therapeutics logo
NeuBase Therapeutics NBSE
$ 0.38 -1.56%

Quarterly report 2023-Q3
added 11-09-2023

report update icon

NeuBase Therapeutics EV/EBITDA Ratio 2011-2024 | NBSE

Annual EV/EBITDA Ratio NeuBase Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.592 -7.26 -1.25 -1.02 -0.644 -3.51 -3.35 -16.8 -28.6 -20.4 -21.3

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.592 -28.6 -9.41